Cerevel Therapeutics Holdings, Inc. EPS - Earnings per Share 2021-2024 | CERE
Cerevel Therapeutics Holdings, Inc. eps - earnings per share from 2021 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Cerevel Therapeutics Holdings, Inc. Annual EPS |
| 2023 |
$-2.67 |
| 2022 |
$-2.32 |
| 2021 |
$-1.65 |
| 2020 |
$-2.01 |
| 2019 |
$-2.90 |
| 2018 |
$-41.23 |
| Cerevel Therapeutics Holdings, Inc. Quarterly EPS |
| 2024-03-31 |
$-0.73 |
| 2023-12-31 |
$-0.76 |
| 2023-09-30 |
$-0.61 |
| 2023-06-30 |
$-0.63 |
| 2023-03-31 |
$-0.67 |
| 2022-12-31 |
$-0.59 |
| 2022-09-30 |
$-0.66 |
| 2022-06-30 |
$-0.61 |
| 2022-03-31 |
$-0.46 |
| 2021-12-31 |
$-0.40 |
| 2021-09-30 |
$-0.43 |
| 2021-06-30 |
$-0.42 |
| 2021-03-31 |
$-0.40 |
| 2020-12-31 |
$-0.08 |
| 2020-09-30 |
$-0.62 |
| 2020-06-30 |
$-0.44 |
| 2020-03-31 |
$-0.87 |
